Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Buyer: | Newcastle University |
| Main Category: | Services |
| Procurement Method: | Restricted procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 6 February 2023 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-03a331 |
| Notice Reference: | 003586-2023 |
The University of Southampton have developed a unique DNA based therapeutic to activate NK cells against cancer. The therapeutic is delivered intramuscularly in combination with DNA encoding the potent immune stimulating cytokine IL-15. The objective is for an Executive to jointly work with the team to bring the opportunity towards and ultimately achieve launch of a new spinout company.
Pipeline status
Not addedContract imported automatically · AI writes the response
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →